From Local Impact to Global Innovation: GE Healthcare’s Vision of Precision Health Puts Wisconsin at the Forefront of Healthcare Technology


By Kelsey Veldkamp and Kate Rodgers


When it comes to impact, not many Wisconsin companies can boast $22.25 million of total economic production output in the state per day. GE Healthcare continues to make a significant impression on Wisconsin through developing partnerships, supporting local innovation, and engaging in community efforts.

Over 250 BioForward Wisconsin members joined on April 26th, 2018 for BioForward’s Annual Member Meeting reviewing a year of achievement for both the organization and its 200+ member companies. BioForward welcomed Jay Hill, Chief Operating Officer of Imaging at GE Healthcare and BioForward Board Member, to share GE Healthcare’s impact on Wisconsin and their vision of the future of precision health.

Precision health considers the individual patient—their genetics and specific environmental factors—when considering treatment and prevention. Precision health will “create better outcomes more efficiently, and make healthcare repeatable, at lower cost, with greater access” explained GE Healthcare’s Jay Hill. Hill went on to say that precision health allows healthcare teams to do “the right thing at the right time for every patient, at scale”.

Precision health takes diagnostics from generic, protocol-driven, qualitative procedures to personalized, quantified techniques. It focuses on targeted therapies and precise delivery of those therapies. The implementation of precision medicine in hospitals initiates a shift from fragmented, department-specific decision making to integrated, interdepartmental health.

Hill described three main categories of innovation GE healthcare sees as integral to precision health: advanced imaging, embedded artificial intelligence, and integration of clinical outputs and medical history.

  1. Advanced Imaging – Over the last century, medical imaging has improved dramatically. Now, we are at the cusp of another imaging revolution, with quantitation and machine learning coming together to gain new information from existing imaging data in a clinical setting. For example, GE healthcare can now visualize blood flow overlaid on a cardiac ultrasound in real time at a level of detail that used to be impossible. This new fidelity of data allows physicians to better detect and understand specific congenital heart defects in children.
  2. Artificial Intelligence and Data Integration – Artificial Intelligence (AI) will reduce the time radiology staff spends reading negative scans and make false negatives less frequent. AI will allow access to radiology for more patients and will fuse imaging data alongside other clinical data.
  3. Connecting Clinical Data and Domains – Precision health is not all about high-tech images and complicated algorithms. Collaboration is essential to the new world of precision health. Data from many different sources must be synthesized and integrated—around the hospital and beyond. A single business cannot solve the healthcare industry’s challenges without input and data from others, but collaborations between corporations will translate to huge gains in technology

To date, most healthcare interventions have been designed with the average patient in mind. This is effective for some patients, but misses the mark for many. The future of medical treatment lies in personalization, quantitative integration, and collaboration. To remain viable and effective, healthcare must evolve, and GE Healthcare is leading the charge toward precision health.

To see the full event summary from BioForward’s Annual Member Meeting, visit the past event page here.

Learn more about GE Healthcare’s commitment to improving precision health here.